<?xml version="1.0" encoding="UTF-8"?>
<itemContainer xmlns="http://omeka.org/schemas/omeka-xml/v5" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://omeka.org/schemas/omeka-xml/v5 http://omeka.org/schemas/omeka-xml/v5/omeka-xml-5-0.xsd" uri="https://neomed.omeka.net/items/browse?tags=beta+Catenin%2Fanalysis%2F%2Abiosynthesis&amp;output=omeka-xml" accessDate="2026-03-16T14:32:03-04:00">
  <miscellaneousContainer>
    <pagination>
      <pageNumber>1</pageNumber>
      <perPage>40</perPage>
      <totalResults>1</totalResults>
    </pagination>
  </miscellaneousContainer>
  <item itemId="5687" public="1" featured="1">
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="55">
          <name>Pages</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="70470">
              <text>264–271</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="56">
          <name>Issue</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="70471">
              <text>1</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="57">
          <name>Volume</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="70472">
              <text>7</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="70462">
                <text>Overexpression of beta-catenin and cyclinD1 predicts a poor prognosis in ovarian serous carcinomas.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="70463">
                <text>International journal of clinical and experimental pathology</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="70464">
                <text>2014</text>
              </elementText>
              <elementText elementTextId="70465">
                <text>1905-07</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="70466">
                <text>Adult; Female; Humans; Middle Aged; Aged; Young Adult; Immunohistochemistry; Neoplasm Staging; Prognosis; Kaplan-Meier Estimate; Up-Regulation; Biomarkers; beta-catenin; beta Catenin/analysis/*biosynthesis; Cyclin D1/analysis/*biosynthesis; cyclinD1; Ovarian Neoplasms/*metabolism/mortality/pathology; ovarian serous carcinoma; prognosis; Cystadenocarcinoma; Serous/*metabolism/mortality/pathology; Tumor/*analysis</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="70467">
                <text>Wang Hai; Wang Haiyan; Makki Mohammad Shahidul; Wen Juanjuan; Dai Yingqing; Shi Qunli; Liu Qi; Zhou Xiaojun; Wang Jiandong</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="70468">
                <text>UNLABELLED: Ovarian serous cancer is the most common subtype of epithelial ovarian cancer, and is the leading cause of death from gynecologic cancer. There is an important need for exploration of diagnostic and prognostic markers for this disease. beta-catenin and cyclinD1 play central roles in the tumorigenesis for certain cancers. The role of beta-catenin and cyclinD1 in diagnosis and prognosis of ovarian serous carcinoma is uncertain. In the present study, the expression of beta-catenin and cyclinD1 was examined in 60 ovarian serous carcinomas patients with immunohistochemical staining. The relationship between expression of beta-catenin and cyclinD1 and FIGO stage, pathological grade was analyzed. Kaplan-Meier survival function was used to analyze the prognosis. Overexpression of beta-catenin is more often detected in patients with FIGO stage III and IV than in those with stage I, and II (P=0.003). No significant relationship was found between expression of beta-catenin and pathological grade (P=0.817). Positive expression of beta-catenin related to lower survival rate (P=0.034). The expression of cyclinD1 had no relationship with FIGO stage (P=0.829). Overexpression of cyclinD1 was positively to pathological grade (P=0.017) and survival rate (P=0.009). There is a significantly positive relationship between expression of beta-catenin and cyclinD1 (P=0.014). No statistical significance was found between expression of beta-catenin and cyclinD1 and other pathological parameters. CONCLUSIONS: Expression of beta-catenin and cyclinD1 may be used as predict markers for poor prognosis.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="70469">
                <text>Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="239">
        <name>2014</name>
      </tag>
      <tag tagId="36">
        <name>Adult</name>
      </tag>
      <tag tagId="175">
        <name>Aged</name>
      </tag>
      <tag tagId="30095">
        <name>beta Catenin/analysis/*biosynthesis</name>
      </tag>
      <tag tagId="7905">
        <name>beta-catenin</name>
      </tag>
      <tag tagId="10154">
        <name>Biomarkers</name>
      </tag>
      <tag tagId="30096">
        <name>Cyclin D1/analysis/*biosynthesis</name>
      </tag>
      <tag tagId="20980">
        <name>cyclinD1</name>
      </tag>
      <tag tagId="3240">
        <name>Cystadenocarcinoma</name>
      </tag>
      <tag tagId="20988">
        <name>Dai Yingqing</name>
      </tag>
      <tag tagId="38">
        <name>Female</name>
      </tag>
      <tag tagId="8">
        <name>Humans</name>
      </tag>
      <tag tagId="258">
        <name>Immunohistochemistry</name>
      </tag>
      <tag tagId="20977">
        <name>International journal of clinical and experimental pathology</name>
      </tag>
      <tag tagId="8575">
        <name>Kaplan-Meier Estimate</name>
      </tag>
      <tag tagId="20990">
        <name>Liu Qi</name>
      </tag>
      <tag tagId="4821">
        <name>Makki Mohammad Shahidul</name>
      </tag>
      <tag tagId="26">
        <name>Middle Aged</name>
      </tag>
      <tag tagId="1348">
        <name>Neoplasm Staging</name>
      </tag>
      <tag tagId="30097">
        <name>Ovarian Neoplasms/*metabolism/mortality/pathology</name>
      </tag>
      <tag tagId="20982">
        <name>ovarian serous carcinoma</name>
      </tag>
      <tag tagId="1350">
        <name>Prognosis</name>
      </tag>
      <tag tagId="30098">
        <name>Serous/*metabolism/mortality/pathology</name>
      </tag>
      <tag tagId="20989">
        <name>Shi Qunli</name>
      </tag>
      <tag tagId="30099">
        <name>Tumor/*analysis</name>
      </tag>
      <tag tagId="2502">
        <name>Up-Regulation</name>
      </tag>
      <tag tagId="20985">
        <name>Wang Hai</name>
      </tag>
      <tag tagId="20986">
        <name>Wang Haiyan</name>
      </tag>
      <tag tagId="20992">
        <name>Wang Jiandong</name>
      </tag>
      <tag tagId="20987">
        <name>Wen Juanjuan</name>
      </tag>
      <tag tagId="2106">
        <name>Young Adult</name>
      </tag>
      <tag tagId="20991">
        <name>Zhou Xiaojun</name>
      </tag>
    </tagContainer>
  </item>
</itemContainer>
